Center-Authored Papers

Filters: Keyword is HIV Envelope Protein gp120  [Clear All Filters]
A
Azoitei ML, Correia BE, Ban Y-EA, Carrico C, Kalyuzhniy O, Chen L, Schroeter A, Huang P-S, McLellan JS, Kwong PD et al..  2011.  Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold.. Science (New York, N.Y.). 334(6054):373-6. Abstract
B
Bolton MJ, Garry RF.  2011.  Sequence similarity between the erythrocyte binding domain 1 of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals binding residues for the Duffy Antigen Receptor for Chemokines.. Virology journal. 8:45. Abstract
D
Dommaraju K, Kijak G, Carlson JM, Larsen BB, Tovanabutra S, Geraghty DE, Deng W, Maust BS, Edlefsen PT, Sanders-Buell E et al..  2014.  CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.. PloS one. 9(10):e111334. Abstract
G
Gilbert PB, Wang M, Wrin T, Petropoulos C, Gurwith M, Sinangil F, D'Souza P, Rodriguez-Chavez IR, DeCamp A, Giganti M et al..  2010.  Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.. The Journal of infectious diseases. 202(4):595-605. Abstract
K
Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu S-lok, Stamatatos L.  2008.  Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.. Journal of virology. 82(12):5912-21. Abstract
L
Lovelace E, Xu H, Blish CA, Strong RK, Overbaugh J.  2011.  The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization.. Virology. 421(2):235-44. Abstract
M
McElrath MJ, Haynes BF.  2010.  Induction of immunity to human immunodeficiency virus type-1 by vaccination.. Immunity. 33(4):542-54. Abstract
T
Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, Tebit DM, Zhao H, Avila S, Lobritz MA et al..  2009.  Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.. PLoS pathogens. 5(4):e1000365. Abstract
V
Vaine M, Wang S, Liu Q, Arthos J, Montefiori D, Goepfert P, McElrath MJ, Lu S.  2010.  Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.. PloS one. 5(11):e13916. Abstract